Filing Flows › Constellium SE (CSTM) › R&D spending
Constellium SE (CSTM) R&D spending by quarter
Constellium SE's R&D spending was $12.0M in Q3 2026 (third quarter 2026), -14% from Q2 2026. Over the last 7 quarters it ranged from $12.0M (Q3 2026) to $14.0M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $12.0M | -14% | 0% |
| Q2 2026 | $14.0M | +8% | +17% |
| Q1 2026 | $13.0M | -7% | 0% |
| Q4 2025 | $14.0M | +17% | — |
| Q3 2025 | $12.0M | 0% | — |
| Q2 2025 | $12.0M | -8% | — |
| Q1 2025 | $13.0M | — | — |
Q3 2026 at a glance
Constellium SE, Q3 2026: revenue $2.6B (+22% year over year), operating margin 6.1%, net earnings $119M, operating cash flow $186M. The chart follows the revenue to costs, profit and cash.
Questions
What is Constellium SE's R&D spending?
Constellium SE's R&D spending was $12.0M in Q3 2026 (third quarter 2026), -14% from Q2 2026.
How has Constellium SE's R&D spending changed?
Over the last 7 quarters it ranged from $12.0M (Q3 2026) to $14.0M (Q2 2026).